Filing Details
- Accession Number:
- 0001415889-23-005032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-16 18:01:52
- Reporting Period:
- 2023-03-14
- Accepted Time:
- 2023-03-16 18:01:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 856982 | Merit Medical Systems Inc | MMSI | Surgical & Medical Instruments & Apparatus (3841) | 870447695 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 901534 | P Fred Lampropoulos | 1600 West Merit Parkway South Jordan UT 84095 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Disposition | 2023-03-14 | 5,278 | $67.66 | 987,615 | No | 4 | S | Direct | |
| Common Stock, No Par Value | Disposition | 2023-03-14 | 19,699 | $68.43 | 967,916 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, No Par Value | 97,077 | Indirect | By 401(k) Plan |
| Common Stock, No Par Value | 6,888 | Indirect | By spouse |
| Common Stock, No Par Value | 90 | Indirect | By spouse as custodian for child |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified stock options (right to buy) | $28.20 | 2018-04-14 | 2024-04-14 | 200,000 | 200,000 | Direct |
| Common Stock | Non-qualified stock options (right to buy) | $28.20 | 2018-04-14 | 2024-04-14 | 6,000 | 6,000 | Indirect |
| Common Stock | Non-qualified stock options (right to buy) | $44.80 | 2019-03-02 | 2025-03-02 | 38,002 | 38,002 | Direct |
| Common Stock | Non-qualified stock options (right to buy) | $44.80 | 2019-03-02 | 2025-03-02 | 4,000 | 4,000 | Indirect |
| Common Stock | Non-qualified stock options (right to buy) | $55.73 | 2020-03-01 | 2026-03-01 | 159,151 | 159,151 | Direct |
| Common Stock | Non-qualified stock options (right to buy) | $55.73 | 2020-03-01 | 2026-03-01 | 2,000 | 2,000 | Indirect |
| Common Stock | Non-qualified stock options (right to buy) | $37.71 | 2021-02-26 | 2027-02-26 | 100,334 | 100,334 | Direct |
| Common Stock | Non-qualified stock options (right to buy) | $56.25 | 2022-03-19 | 2028-03-19 | 58,083 | 58,083 | Direct |
| Common Stock | Non-qualified stock options (right to buy) | $70.58 | 2024-02-28 | 2030-02-28 | 54,302 | 54,302 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2024-04-14 | 200,000 | 200,000 | Direct |
| 2024-04-14 | 6,000 | 6,000 | Indirect |
| 2025-03-02 | 38,002 | 38,002 | Direct |
| 2025-03-02 | 4,000 | 4,000 | Indirect |
| 2026-03-01 | 159,151 | 159,151 | Direct |
| 2026-03-01 | 2,000 | 2,000 | Indirect |
| 2027-02-26 | 100,334 | 100,334 | Direct |
| 2028-03-19 | 58,083 | 58,083 | Direct |
| 2030-02-28 | 54,302 | 54,302 | Direct |
Footnotes
- The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.99 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.00 to $68.75 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- Represents plan holdings as of 3/14/2023.
- Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.
- Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 4/14/2018. Options not vested as of 6/22/2020 have been forfeited.
- Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
- Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.
- Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/2/2019. Options not vested as of 6/22/2020 have been forfeited.
- Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
- Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.
- Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
- Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
- Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Billionaire Hedge Funds
